Form 8-K - Current report:
SEC Accession No. 0001023024-06-000038
Filing Date
2006-11-08
Accepted
2006-11-08 16:48:54
Documents
1
Period of Report
2006-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 BIOSANTE AGREEMENT WITH BRADLEY PHARMACEUTICALS bradleydeal.htm 8-K 24277
  Complete submission text file 0001023024-06-000038.txt   25867
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 061198095
SIC: 2836 Biological Products, (No Diagnostic Substances)